Trevi Therapeutics, Inc. TRVI
15.31 USD +0.98 (+6.84%)
At closeNov 9, 2026, 4:00 PM EST
15.84 +0.53 +3.46%
After hours · Nov 9, 4:00 PM ET
14.35 Day range 15.49
9.82 52-week range 20.22
- YTD
- +22.28%
- 1 year
- +39.06%
Financial health
Altman Z-Score
135.04 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 5
- P/E 1
- P/B 1